02 March 2023

GSK Stockmann in Luxembourg again certified as Great Place to Work®

GSK Stockmann in Luxembourg has again been certified as Great Place to Work® for January 2023-January 2024 based on an anonymous online survey with more than 60 questions conducted by the Great Place to Work® Institute. As a result of the study, the trust index shows that 97 % of the employees say that GSK Stockmann in Luxembourg is a Great Place to Work®.

Founded in the United States, the Great Place to Work® Institute has been spreading its methodology through Europe after it won a call for tenders launched by the European Commission in order to recognize Best Workplaces® in Europe. The Great Place to Work® Institute specialises on workplace culture, helping organisations to create exceptional, high performing workplaces where employees feel trusted and valued. The methodology behind is one of the most rigorous available and comprises an employee survey followed by a culture audit relating to management and HR practices. The results of the survey are a barometer to understand employees’ perception on their work environment.

Dr. Philipp Mössner, Partner in charge of HR at GSK Stockmann in Luxembourg, comments: “We are very pleased to be again recognized as a Great Place to Work®. The results are based on the positive feedback from our lawyers and employees alike and show that our firm is a true collaborative and positive workplace. The certification underlines our successful development combined with our strong focus on firm culture and values. Therefore, we would like to express our sincere thanks to our entire team for contributing to establish a Great Place to Work®.”

Further information regarding the Great Place to Work® certification can be found on the following website: https://www.greatplacetowork.lu/fr/


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
Contact person

Dr. Philipp Mössner, LL.M. (McGill)


+352 271802-40


© GSK Stockmann 2024